Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Cannabis

The Valens Company congratulates Green Roads co-founder Laura Fuentes on her inclusion in Forbes' 50 over 50

Forbes 50 Over 50 platform recognizes women who are shaping the future of science, technology and art

The Valens Company (TSX:VLNS, OTCQX:VLNCF) Inc has announced that Laura Fuentes, co-founder of its US-based Green Roads subsidiary, has been recognized as a member of Forbes' inaugural 50 over 50: Vision List.

Forbes 50 Over 50 platform recognizes women who are shaping the future of science, technology and art, and is dedicated to highlighting women over the age of 50 who have achieved significant success later in life, often overcoming formidable odds or barriers.

“On behalf of the Valens team, we congratulate Laura on this recognition of her achievements in the field of cannabis,” The Valens Company (TSX:VLNS, OTCQX:VLNCF) CEO Tyler Robson said in a statement.

READ: The Valens Company achieves significant step toward Quebec market entry

“There are so few female leaders in the cannabis industry, which makes Laura's contributions to breaking gender norms and shaping the future of our industry even more meaningful,” Robson added.

Before co-founding Green Roads, Fuentes spent 25 years as a licensed compound pharmacist. Under her leadership, the company was one of the first to require independent lab testing on every product batch and one of the first to make every lab report readily available to consumers.

Green Roads, which produces gummies, oils, topicals, capsules and other products, was the largest privately-owned CBD company in the US when Valens acquired the company in June 2021.

The Valens Company (TSX:VLNS, OTCQX:VLNCF) is a profitable British Columbia-based producer of cannabis products, medical and recreational, and it is scaling up operations. The company can process over 425,000 kilograms of biomass per year and its services include numerous types of proprietary extraction, analytical testing, formulation, cultivation, and research, as well as white label product development.

Valens’ products include tinctures, two-piece caps, soft gels, oral sprays, and vape pens as well as beverages, edibles, injectables, and natural health products and it has a strong pipeline of next-generation products in development.

Contact Sean at sean@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK